Boston Historical Income Statement

BSX Stock

USD 67.33 0.09 0.13%

Historical analysis of Boston Scientific income statement accounts such as Interest Expense of 193.9 M, Selling General Administrative of 5.2 B or Total Revenue of 15 B can show how well Boston Scientific Corp performed in making a profits. Evaluating Boston Scientific income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Boston Scientific's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Boston Scientific Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Boston Scientific Corp is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

About Boston Income Statement Analysis

Boston Scientific Corp Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Boston Scientific shareholders. The income statement also shows Boston investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Boston Scientific Income Statement Chart

Boston Scientific Corp Income Statement is one of the three primary financial statements used for reporting Boston's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Boston Scientific Corp revenue and expense. Boston Scientific Income Statement primarily focuses on the company's revenues and expenses during a particular period.

At this time, Boston Scientific's Income Before Tax is fairly stable compared to the past year. Net Income is likely to rise to about 1.7 B in 2024, whereas Interest Expense is likely to drop slightly above 193.9 M in 2024.

Selling General Administrative Total Revenue Gross Profit Other Operating Expenses

Total Revenue

Total revenue comprises all receipts Boston Scientific Corp generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Boston Scientific Corp minus its cost of goods sold. It is profit before Boston Scientific operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Boston Scientific Corp. It is also known as Boston Scientific overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Boston Scientific's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Boston Scientific Corp current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

	2021	2022	2023	2024 (projected)
Gross Profit	8.1B	8.7B	9.9B	10.4B
Total Revenue	11.9B	12.7B	14.2B	15.0B

Gross Profit Total Revenue

Boston Scientific income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Research Development	Selling And Marketing Expenses	Net Income From Continuing Ops	Non Recurring	Non Operating Income Net Other	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Extraordinary Items
Depreciation And Amortization		0.43	0.93	0.94	0.93	0.94	0.6	0.83	0.92	0.94	0.93	0.55	0.22	0.33	0.2	0.73	-0.67	0.36	-0.28	0.06	0.36	-0.2	-0.45	0.51	0.81
Interest Expense	0.43		0.59	0.56	0.54	0.58	0.2	0.33	0.38	0.59	0.57	0.06	-0.15	0.31	-0.43	0.79	0.2	0.44	-0.02	-0.1	-0.37	0.19	-0.77	0.09	0.49
Selling General Administrative	0.93	0.59		1.0	0.99	1.0	0.59	0.88	0.94	0.98	1.0	0.51	0.15	0.43	-0.01	0.87	-0.54	0.5	-0.23	0.02	0.16	-0.3	-0.47	0.44	0.78
Total Revenue	0.94	0.56	1.0		1.0	0.99	0.59	0.91	0.96	0.99	0.99	0.52	0.15	0.42	0.01	0.85	-0.58	0.49	-0.22	0.0	0.18	-0.32	-0.45	0.45	0.78
Gross Profit	0.93	0.54	0.99	1.0		0.99	0.61	0.91	0.96	0.97	0.99	0.54	0.18	0.45	-0.01	0.84	-0.59	0.51	-0.25	-0.04	0.17	-0.36	-0.44	0.44	0.77
Other Operating Expenses	0.94	0.58	1.0	0.99	0.99		0.56	0.87	0.93	0.99	1.0	0.48	0.12	0.39	0.01	0.86	-0.56	0.46	-0.19	0.05	0.18	-0.28	-0.47	0.47	0.8
Operating Income	0.6	0.2	0.59	0.59	0.61	0.56		0.64	0.65	0.54	0.57	0.98	0.85	0.81	-0.01	0.41	-0.41	0.79	-0.89	-0.01	0.12	-0.34	-0.37	0.34	0.63
Ebit	0.83	0.33	0.88	0.91	0.91	0.87	0.64		0.98	0.88	0.85	0.62	0.25	0.46	0.09	0.71	-0.64	0.5	-0.28	-0.02	0.22	-0.45	-0.23	0.36	0.65
Ebitda	0.92	0.38	0.94	0.96	0.96	0.93	0.65	0.98		0.94	0.92	0.62	0.25	0.43	0.13	0.75	-0.68	0.47	-0.29	0.01	0.28	-0.38	-0.32	0.43	0.74
Cost Of Revenue	0.94	0.59	0.98	0.99	0.97	0.99	0.54	0.88	0.94		0.97	0.45	0.07	0.34	0.05	0.86	-0.55	0.41	-0.15	0.1	0.2	-0.21	-0.47	0.46	0.8
Total Operating Expenses	0.93	0.57	1.0	0.99	0.99	1.0	0.57	0.85	0.92	0.97		0.49	0.14	0.41	-0.02	0.85	-0.56	0.48	-0.22	0.02	0.17	-0.32	-0.47	0.47	0.79
Income Before Tax	0.55	0.06	0.51	0.52	0.54	0.48	0.98	0.62	0.62	0.45	0.49		0.91	0.79	0.06	0.31	-0.44	0.75	-0.91	-0.08	0.18	-0.4	-0.23	0.29	0.51
Total Other Income Expense Net	0.22	-0.15	0.15	0.15	0.18	0.12	0.85	0.25	0.25	0.07	0.14	0.91		0.71	0.06	-0.01	-0.23	0.65	-0.97	-0.09	0.12	-0.3	-0.09	0.17	0.22
Net Income	0.33	0.31	0.43	0.42	0.45	0.39	0.81	0.46	0.43	0.34	0.41	0.79	0.71		-0.57	0.31	-0.24	0.99	-0.79	-0.39	-0.46	-0.46	-0.47	0.35	0.53
Income Tax Expense	0.2	-0.43	-0.01	0.01	-0.01	0.01	-0.01	0.09	0.13	0.05	-0.02	0.06	0.06	-0.57		-0.1	-0.21	-0.59	0.06	0.52	0.98	0.21	0.45	-0.17	-0.18
Research Development	0.73	0.79	0.87	0.85	0.84	0.86	0.41	0.71	0.75	0.86	0.85	0.31	-0.01	0.31	-0.1		-0.11	0.43	-0.09	0.07	0.03	-0.17	-0.51	0.33	0.6
Selling And Marketing Expenses	-0.67	0.2	-0.54	-0.58	-0.59	-0.56	-0.41	-0.64	-0.68	-0.55	-0.56	-0.44	-0.23	-0.24	-0.21	-0.11		-0.19	0.21	0.11	-0.32	0.42	-0.08	-0.55	-0.53
Net Income From Continuing Ops	0.36	0.44	0.5	0.49	0.51	0.46	0.79	0.5	0.47	0.41	0.48	0.75	0.65	0.99	-0.59	0.43	-0.19		-0.74	-0.37	-0.47	-0.46	-0.51	0.33	0.53
Non Recurring	-0.28	-0.02	-0.23	-0.22	-0.25	-0.19	-0.89	-0.28	-0.29	-0.15	-0.22	-0.91	-0.97	-0.79	0.06	-0.09	0.21	-0.74		0.13	-0.02	0.31	0.25	-0.22	-0.34
Non Operating Income Net Other	0.06	-0.1	0.02	0.0	-0.04	0.05	-0.01	-0.02	0.01	0.1	0.02	-0.08	-0.09	-0.39	0.52	0.07	0.11	-0.37	0.13		0.5	0.41	0.1	0.01	0.07
Tax Provision	0.36	-0.37	0.16	0.18	0.17	0.18	0.12	0.22	0.28	0.2	0.17	0.18	0.12	-0.46	0.98	0.03	-0.32	-0.47	-0.02	0.5		0.1	0.38	-0.06	-0.03
Interest Income	-0.2	0.19	-0.3	-0.32	-0.36	-0.28	-0.34	-0.45	-0.38	-0.21	-0.32	-0.4	-0.3	-0.46	0.21	-0.17	0.42	-0.46	0.31	0.41	0.1		-0.24	-0.41	-0.08
Net Interest Income	-0.45	-0.77	-0.47	-0.45	-0.44	-0.47	-0.37	-0.23	-0.32	-0.47	-0.47	-0.23	-0.09	-0.47	0.45	-0.51	-0.08	-0.51	0.25	0.1	0.38	-0.24		-0.16	-0.72
Reconciled Depreciation	0.51	0.09	0.44	0.45	0.44	0.47	0.34	0.36	0.43	0.46	0.47	0.29	0.17	0.35	-0.17	0.33	-0.55	0.33	-0.22	0.01	-0.06	-0.41	-0.16		0.58
Extraordinary Items	0.81	0.49	0.78	0.78	0.77	0.8	0.63	0.65	0.74	0.8	0.79	0.51	0.22	0.53	-0.18	0.6	-0.53	0.53	-0.34	0.07	-0.03	-0.08	-0.72	0.58

Click cells to compare fundamentals

Boston Scientific Account Relationship Matchups

Boston Scientific income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	564M	789M	741M	1.2B	1.2B	1.3B
Interest Expense	473M	361M	341M	470M	265M	193.9M
Selling General Administrative	3.9B	3.8B	4.4B	4.5B	5.0B	5.2B
Total Revenue	10.7B	9.9B	11.9B	12.7B	14.2B	15.0B
Gross Profit	7.6B	6.4B	8.1B	8.7B	9.9B	10.4B
Other Operating Expenses	9.0B	9.2B	10.1B	10.6B	11.8B	12.4B
Operating Income	1.5B	1.0B	2.0B	1.6B	2.3B	2.5B
Ebit	1.5B	1.0B	2.0B	1.6B	2.4B	2.5B
Ebitda	2.1B	1.8B	2.8B	2.8B	3.6B	3.8B
Cost Of Revenue	3.2B	3.5B	3.8B	4.0B	4.3B	4.6B
Total Operating Expenses	5.8B	5.7B	6.3B	6.6B	7.5B	7.9B
Income Before Tax	687M	(138M)	1.1B	1.1B	2.0B	2.1B
Total Other Income Expense Net	(831M)	(1.2B)	(967M)	(508M)	(188M)	(197.4M)
Net Income	4.7B	(140M)	1.0B	698M	1.6B	1.7B
Income Tax Expense	(4.0B)	2M	36M	443M	393M	412.7M
Research Development	1.2B	1.1B	1.2B	1.3B	1.4B	884.9M
Net Income Applicable To Common Shares	4.7B	(115M)	986M	642M	738.3M	775.2M
Net Income From Continuing Ops	4.7B	(81M)	1.0B	698M	1.2B	1.3B
Non Recurring	323M	908M	889M	376M	338.4M	321.5M
Non Operating Income Net Other	(358M)	362M	218M	(38M)	(43.7M)	(41.5M)
Tax Provision	(4.0B)	2M	36M	443M	647M	679.4M
Interest Income	30M	361M	341M	470M	22M	20.9M
Net Interest Income	(443M)	(361M)	(341M)	(470M)	(254M)	(266.7M)
Reconciled Depreciation	1.0B	1.1B	741M	803M	1.2B	1.0B

Boston Scientific Investors Sentiment

The influence of Boston Scientific's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Boston. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.

Investor biases related to Boston Scientific's public news can be used to forecast risks associated with an investment in Boston. The trend in average sentiment can be used to explain how an investor holding Boston can time the market purely based on public headlines and social activities around Boston Scientific Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Boston Scientific's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Boston Scientific's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Boston Scientific's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Boston Scientific.

Boston Scientific Implied Volatility

49.01

Boston Scientific's implied volatility exposes the market's sentiment of Boston Scientific Corp stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Boston Scientific's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Boston Scientific stock will not fluctuate a lot when Boston Scientific's options are near their expiration.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Boston Scientific in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Boston Scientific's short interest history, or implied volatility extrapolated from Boston Scientific options trading.

Pair Trading with Boston Scientific

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Boston Scientific position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boston Scientific will appreciate offsetting losses from the drop in the long position's value.

Moving together with Boston Stock

0.8	ELMD	Electromed	Pair Corr
0.76	FEMY	Femasys Financial Report 9th of May 2024	Pair Corr

Moving against Boston Stock

0.89	IVP	Inspire Veterinary	Pair Corr
0.82	EMBC	Embecta Corp Financial Report 10th of May 2024	Pair Corr
0.72	TFX	Teleflex Incorporated Financial Report 2nd of May 2024	Pair Corr
0.51	DYNT	Dynatronics Financial Report 9th of May 2024	Pair Corr

The ability to find closely correlated positions to Boston Scientific could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Boston Scientific when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Boston Scientific - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Boston Scientific Corp to buy it.

The correlation of Boston Scientific is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Boston Scientific moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Boston Scientific Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Boston Scientific can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Boston Scientific Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Boston Scientific's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Boston Scientific Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Boston Scientific Corp Stock:

How To Invest In Boston

Details

Is Boston Stock a good investment?

Details

What is Boston Scientific's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Boston Stock analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.

	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Fundamental Analysis View fundamental data based on most recent published financial statements
	CEOs Directory Screen CEOs from public companies around the world
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk

Is Boston Scientific's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boston Scientific. If investors know Boston will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boston Scientific listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

2.856

Earnings Share

1.07

Revenue Per Share

9.8

Quarterly Revenue Growth

0.149

Return On Assets

0.0447

The market value of Boston Scientific Corp is measured differently than its book value, which is the value of Boston that is recorded on the company's balance sheet. Investors also form their own opinion of Boston Scientific's value that differs from its market value or its book value, called intrinsic value, which is Boston Scientific's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boston Scientific's market value can be influenced by many factors that don't directly affect Boston Scientific's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Boston Scientific's value and its price as these two are different measures arrived at by different means. Investors typically determine if Boston Scientific is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boston Scientific's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Boston Historical Income Statement

About Boston Income Statement Analysis

Boston Scientific Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Boston Scientific income statement Correlations

Boston Scientific Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Boston Scientific income statement Accounts

Boston Scientific Investors Sentiment

Boston Scientific Implied Volatility

Pair Trading with Boston Scientific

Moving together with Boston Stock

Moving against Boston Stock

Complementary Tools for Boston Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Revenue	+ 1.0	Selling General Administrative
Other Operating Expenses	+ 1.0	Selling General Administrative
Total Operating Expenses	+ 1.0	Selling General Administrative
Gross Profit	+ 1.0	Total Revenue
Total Operating Expenses	+ 1.0	Other Operating Expenses
Gross Profit	+ 0.99	Selling General Administrative

Non Recurring	- 0.97	Total Other Income Expense Net
Non Recurring	- 0.91	Income Before Tax
Non Recurring	- 0.89	Operating Income
Non Recurring	- 0.79	Net Income
Net Interest Income	- 0.77	Interest Expense
Non Recurring	- 0.74	Net Income From Continuing Ops